Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Blis finally cracks an annual profit

Blis finally cracks an annual profit after almost 18 years of public life

By Paul McBeth

May 28 (BusinessDesk) - Blis Technologies reported a maiden profit, almost 18 years since listing, and the probiotic maker expects to chalk up a bigger profit in the coming year on growing international demand for its probiotic products.

The Dunedin-based company reported a profit of $381,000 in the 12 months ended March 31, turning around a loss of $1 million a year earlier. Revenue climbed 59 percent to $5.3 million, with double-digit growth in New Zealand, the Asia Pacific, and North America. Earnings before interest, tax, depreciation and amortisation were $896,000, turning around an ebitda-loss of $422,000 a year earlier.

Blis listed in July 2001 and chair Tony Offen describes the profit achievement as a "significant turning point" for the company, which has retained losses totalling $34 million since it was founded in 2000.

"While we are very pleased with the financial progress made to date, and have been encouraged by the early results from a number of new market launch initiatives, challenges in the 2019 year included dealing with long lead times to progress new customer initiatives, overcoming delays in new regulatory approvals and managing targeted accelerated growth opportunities on a limited budget," Offen said.

The company forecasts sustained profitable growth for the year ending March 31, 2020, but it is still forecasting a flat ebitda in line with the $896,000 just reported.

Operating cash flow was a net outflow of $583,000 in the year, compared to a net inflow of $118,000 and it scaled back investment spending to $130,000 from $476,000. It held cash and equivalents of $924,000 at March 31, down from $1.1 million a year earlier.

The company also had working capital of $2.3 million, which the board deemed sufficient to meet its needs over the next 12 months when signing off on the accounts on a going concern basis.

Blis was formed to commercialise probiotic bacteria for use in consumer products for oral health, colds and flu. In 2000, it bought Otago University's rights to Salivaricin B, a substance which acts as a natural antibiotic to control strep throat.

The firm has had a few false dawns in hitting profitability, but last month said its annual revenue and underlying earnings beat guidance on strong orders across all its international markets.

Australian sales got a boost from an exclusive distribution agreement with iNova Pharmaceuticals, making Blis Technologies' expanded product range available in 5,000 pharmacies. Blis said iNova is currently evaluating where to launch the next phase of international expansion into certain African and Asian markets.

Blis said the maiden profit showed the firm in a strong position, not just with a wider revenue mix, but also its internal capability and the regulatory approvals it's gained.

"Key growth opportunities for the company in FY20 include Canada, China cross-border and daigou markets, market expansion in Asia and Africa with iNova Pharmaceuticals and expansion of our online sales," it said.

The shares rose 5 percent, or 0.2 of a cent, to 4.2 cents. They've more than doubled so far this year, making it the second-best performer on the S&P/NZX All Index.



© Scoop Media

Business Headlines | Sci-Tech Headlines


Financial Markets Authority: Online Investing Platforms Transform Attitudes To Investing

Eight out of 10 New Zealand investors have a more favourable view of investing and financial markets after using online investing platforms, according to research released today by the Financial Markets Authority - Te Mana Tātai Hokohoko... More>>

Barfoot and Thompson: Auckland Housing Prices Shrug Off Winter Concerns

Auckland house prices shrugged off the normal winter downturn, concerns about increasing prices and warnings of possible future interest rate rises in July.
“Mounting concerns about the prices being paid and possible future interest rate increases did nothing to dampen July trading... More>>

Stats NZ: Sharp Falls In Unemployment And Underutilisation

The seasonally adjusted unemployment and underutilisation rates fell to 4.0 and 10.5 percent, respectively, in the June 2021 quarter, Stats NZ said today. The unemployment rate continued to fall from its recent peak of 5.3 percent in the September 2020 quarter... More>>

ASB: Labour Shortage Sting Set To Cause Issues For Years According To Latest Quarterly Economic Forecast

There are positives and negatives in the latest ASB Quarterly Economic Forecast as New Zealand continues to bounce back strongly from COVID-19. The closed border is putting additional strain on the country’s labour market... More>>

Transport: July 2021 New Vehicle Registrations Boosted By EV Rebate Scheme
Motor Industry Association Chief Executive David Crawford says that July 2021 sales of new vehicles were boosted by the recently introduced rebate scheme. July 2021 registrations were 15,053 units compared to 12,263 units for July 2020... More>>

ASB: New Support Finder Tool Helps Connect Customers With Thousands In Government Support

ASB research alongside benefit numbers from the Ministry of Social Development shows an increased number of Kiwis are struggling financially, and many may not be aware they’re eligible for government support... More>>